Alembic Pharmaceuticals informs about press release

28 Jun 2024 Evaluate
Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Final Approval for Doxycycline Capsules, 40 mg. It enclosed press release.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

767.15 -9.10 (-1.17%)
19-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1713.20
Dr. Reddys Lab 1279.75
Cipla 1329.05
Zydus Lifesciences 902.25
Lupin 2228.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×